The second wave of corona infection in the country has now come under control to a great extent. The Health Department is constantly trying to control the situation. The Defense Research and Development Organization (DRDO), which developed the drug 2-deoxy-D-glucose (2-DG), used in the treatment of Covid-19 patients, has decided to transfer the technology of making this drug to the Indian pharmaceutical industry. Expressions of Interest (EOIs) are invited.
The medicine helps in recovering from the disease faster
The 2-DG drug has been developed by DRDO's laboratory, Institute of Nuclear Medicine and Allied Sciences (INMAS) in association with Dr. Reddy Laboratories. Clinical trial results showed that it helps hospitalized patients recover faster and reduce their dependence on oxygen.
Application to be sent before June 17
As per the EOI document, applications should be sent through email before June 17. "The EoIs to be given by the industries will be examined by a Technical Assessment Committee (TAC)," it added. Only 15 industries will be given ToT based on their capabilities and first come first serve. The bidders should have a license to manufacture drugs from active pharmaceutical ingredients (APIs) from drug licensing authorities.
DRDO issued guidelines
DRDO had earlier issued guidelines regarding the use of 2-DG medicine. It has been clearly stated by the organization that this medicine should be given to the patients of Covid-19 only under the supervision and prescription of the doctors. In the guidelines issued by DRDO, it has been said that 2-DG medicine is only for emergency use of corona patients. This drug should be used as adjunctive therapy in hospitalized corona patients. It should be used only based on the advice of doctors for the treatment of moderate and severe patients of the corona. Do not take this medicine without medical advice.
The winter session of Parliament is expected to begin next month. Assembly elections are due in f
Army Chief General Upendra Dwivedi has said that the Indian Army has prepared a framework for the
North India, which is scorching by the scorching heat, may soon get some relief from its outbreak
After Pfizer and Moderna, the Serum Institute of India (SII), which manufactures the Corona Vacci
Before the MCD elections, BJP showed a sting operation on Monday. Claimed that AAP leaders are de
Coronavirus cases are increasing again around the world. Vaccination work is also going on in ful
Delhi Weather Update: Amidst the bitter cold, the minimum temperature in the capital has dropped
After the snowfall in the mountains, now the cold has started increasing in the plains. In many s
Coal India: Adequate supply of fuel to power plants, first tender issued for coal import
State-owned CIL on Thursday said it has floated its first tender for the import of 2.416 million
Samajwadi Party President Akhilesh Yadav is stuck in Delhi before reaching Muzaffarnagar. He has
